ABBOTT LABORATORIES — Director's Dealing 2015

Apr 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-03-31

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-31	Common shares without par value	A	1042	—	Acquired	2421	Indirect
2015-03-31	Common shares without par value	F	99	$47.08	Disposed	2322	Indirect
2015-03-31	Common shares without par value	S	228	$46.431	Disposed	2094	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	36898	Direct
Common shares without par value	20	Indirect
Common shares without par value	63903	Indirect
Common shares without par value	12081	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2015.

F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F3: This grant represents a restricted stock unit award under the Abbott Laboratories 2009 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting on each anniversary of the grant date. The award includes the right to have stock withheld for tax purposes.

F4: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.